- Home
- LSBK vs ASRT Comparison
LSBK vs ASRT Comparison
Compare LSBK & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- ASRT
- Stock Information
- Founded
- LSBK 1891
- ASRT 1995
- Country
- LSBK United States
- ASRT United States
- Employees
- LSBK N/A
- ASRT N/A
- Industry
- LSBK Savings Institutions
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- LSBK Finance
- ASRT Health Care
- Exchange
- LSBK Nasdaq
- ASRT Nasdaq
- Market Cap
- LSBK 77.2M
- ASRT 91.3M
- IPO Year
- LSBK 2006
- ASRT 1997
- Fundamental
- Price
- LSBK $13.70
- ASRT $0.90
- Analyst Decision
- LSBK
- ASRT Strong Buy
- Analyst Count
- LSBK 0
- ASRT 4
- Target Price
- LSBK N/A
- ASRT $3.19
- AVG Volume (30 Days)
- LSBK 955.0
- ASRT 908.1K
- Earning Date
- LSBK 01-29-2025
- ASRT 11-11-2024
- Dividend Yield
- LSBK 5.20%
- ASRT N/A
- EPS Growth
- LSBK N/A
- ASRT N/A
- EPS
- LSBK 0.74
- ASRT N/A
- Revenue
- LSBK $25,338,000.00
- ASRT $125,763,000.00
- Revenue This Year
- LSBK N/A
- ASRT N/A
- Revenue Next Year
- LSBK N/A
- ASRT $1.84
- P/E Ratio
- LSBK $18.65
- ASRT N/A
- Revenue Growth
- LSBK N/A
- ASRT N/A
- 52 Week Low
- LSBK $10.30
- ASRT $0.73
- 52 Week High
- LSBK $14.21
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- LSBK 62.66
- ASRT 43.20
- Support Level
- LSBK $13.44
- ASRT $0.90
- Resistance Level
- LSBK $13.67
- ASRT $1.04
- Average True Range (ATR)
- LSBK 0.02
- ASRT 0.06
- MACD
- LSBK 0.05
- ASRT -0.00
- Stochastic Oscillator
- LSBK 100.00
- ASRT 14.84
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.